Chaohui Yu Selected Research

3-mercaptopyruvate sulphurtransferase

1/2022	Response to the clinical significance and prognostic value of 3-mercaptopyruvate sulfurtransferase in hepatocellular carcinoma.
1/2022	3-Mercaptopyruvate sulfurtransferase represses tumour progression and predicts prognosis in hepatocellular carcinoma.
12/2018	Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chaohui Yu Research Topics

Disease

35	Non-alcoholic Fatty Liver Disease 01/2022 - 09/2008
10	Inflammation (Inflammations) 12/2021 - 02/2014
7	Insulin Resistance 01/2022 - 04/2016
6	Neoplasms (Cancer) 09/2021 - 02/2010
5	Obesity 01/2022 - 09/2008
5	Infections 01/2022 - 12/2014
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 09/2010
5	Colitis 05/2021 - 09/2010
4	Fibrosis (Cirrhosis) 01/2022 - 03/2011
4	Liver Diseases (Liver Disease) 01/2019 - 10/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2016 - 05/2009
3	Crohn Disease (Crohn's Disease) 01/2022 - 01/2015
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2020
3	Body Weight (Weight, Body) 01/2022 - 01/2021
3	Hyperglycemia 01/2022 - 09/2009
3	Metabolic Diseases (Metabolic Disease) 02/2021 - 04/2017
3	Fatty Liver 10/2019 - 01/2017
3	Hyperuricemia 06/2015 - 05/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2021
2	Dyslipidemias (Dyslipidemia) 01/2021 - 05/2014
2	Hypertension (High Blood Pressure) 04/2017 - 05/2014
2	Adenocarcinoma 01/2017 - 07/2016
1	Esophageal Achalasia (Megaesophagus) 01/2022
1	Hypertrophy 01/2022
1	Ulcer 10/2021
1	Liver Neoplasms (Liver Cancer) 09/2021
1	Duodenal Ulcer (Curling's Ulcer) 02/2021
1	Stomach Ulcer (Gastric Ulcer) 02/2021
1	Peptic Ulcer (Peptic Ulcers) 02/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Hypokalemia 01/2021
1	Celiac Disease (Celiac Sprue) 01/2021
1	Arthritis (Polyarthritis) 07/2020
1	Experimental Arthritis 07/2020
1	Ulcerative Colitis 02/2020

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
6	LipidsIBA 01/2022 - 05/2014
6	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2021 - 02/2014
6	Uric Acid (Urate)IBA 01/2021 - 05/2009
5	InflammasomesIBA 01/2021 - 06/2015
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2010
4	Messenger RNA (mRNA)IBA 01/2022 - 02/2014
4	Long Noncoding RNAIBA 01/2022 - 01/2017
4	Vitamin D FDA LinkGeneric 01/2021 - 01/2015
4	EnzymesIBA 12/2018 - 07/2002
3	3-mercaptopyruvate sulphurtransferaseIBA 01/2022 - 12/2018
3	XenobioticsIBA 01/2022 - 04/2019
3	Methionine (L-Methionine)FDA Link 12/2021 - 06/2011
3	Choline (Choline Chloride)IBA 12/2021 - 06/2011
3	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 11/2015
3	Dextran SulfateIBA 01/2021 - 09/2010
3	Triglycerides (Triacylglycerol)IBA 01/2017 - 08/2013
3	Hemoglobins (Hemoglobin)IBA 01/2017 - 01/2012
2	Constitutive Androstane ReceptorIBA 01/2022 - 02/2021
2	Benzene (Benzole)IBA 01/2022 - 02/2021
2	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 06/2011
2	Capsules (Microcapsules)IBA 10/2021 - 01/2014
2	entinostat (MS 275)IBA 05/2021 - 09/2020
2	Histones (Histone)IBA 05/2021 - 09/2020
2	Protons (Proton)IBA 02/2021 - 06/2011
2	ORALIT (ORS)IBA 02/2021 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
2	oxidized low density lipoproteinIBA 01/2021 - 01/2017
2	Sirtuin 1IBA 10/2019 - 09/2015
2	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2009
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2018 - 11/2015
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2013 - 08/2011
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022
1	alanylaspartic acidIBA 01/2022
1	aspartylglutamateIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	CollagenIBA 01/2022
1	Dextrans (Dextran)FDA Link 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	Caveolin 1IBA 01/2022
1	Connective Tissue Growth FactorIBA 01/2022
1	Insulin-Like Growth Factor Binding Protein 1IBA 12/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	Infliximab (Remicade)FDA Link 12/2021
1	Vancomycin FDA LinkGeneric 10/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2021
1	Particulate MatterIBA 02/2021
1	1,4- bis(2- (3,5- dichloropyridyloxy))benzeneIBA 02/2021
1	sym-trinitrobenzeneIBA 01/2021
1	PotassiumIBA 01/2021
1	tetrahydropalmatineIBA 01/2021
1	Sulfonic AcidsIBA 01/2021
1	Chemotactic FactorsIBA 01/2021
1	NF-kappa B (NF-kB)IBA 09/2020
1	Pharmaceutical PreparationsIBA 09/2020
1	HMGB1 Protein (HMG1)IBA 09/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2020

Therapy/Procedure

4	Therapeutics 02/2020 - 03/2011
2	Lasers (Laser) 03/2019 - 04/2010
2	Transplantation 07/2016 - 09/2008
2	Surgical Instruments (Clip) 07/2016 - 02/2015
2	Ligation 01/2016 - 03/2011
1	Aftercare (After-Treatment) 10/2021
1	Radiotherapy 09/2021